2021
DOI: 10.7717/peerj.11073
|View full text |Cite
|
Sign up to set email alerts
|

Association between uric acid lowering and renal function progression: a longitudinal study

Abstract: Background This study aimed to explore the association between uric acid lowering and renal function. Materials and Methods We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…For all three models, the various Mach-L methods all selected UA as the key factor for determining L-eGFR, a finding supported by previous work. In a four-year longitudinal study, Liu et al [ 29 ] showed that compared to the highest quartile of UA, subjects with lower UA (quartile 1) are at lower risk for having reduced renal function [hazard ratio = 0.64, 95% confidence interval (0.49–0.85)]. Zhang et al [ 30 ] reviewed ten randomized controlled trials, finding that, following febuxostate treatment, eGFR was consistently and significantly lower than that in the non-treatment group.…”
Section: Discussionmentioning
confidence: 99%
“…For all three models, the various Mach-L methods all selected UA as the key factor for determining L-eGFR, a finding supported by previous work. In a four-year longitudinal study, Liu et al [ 29 ] showed that compared to the highest quartile of UA, subjects with lower UA (quartile 1) are at lower risk for having reduced renal function [hazard ratio = 0.64, 95% confidence interval (0.49–0.85)]. Zhang et al [ 30 ] reviewed ten randomized controlled trials, finding that, following febuxostate treatment, eGFR was consistently and significantly lower than that in the non-treatment group.…”
Section: Discussionmentioning
confidence: 99%
“…Improvement of renal function can be attributed to decrease in uric acid level, inhibition of oxidative stress and reduced signal transduction of renal brosis induced by febuxostat [38][39][40].…”
Section: Discussionmentioning
confidence: 99%